Distribution of health care expenditures for HIV-infected patients. - Wikidata - wikimedia - TriplyDB

Distribution of health care expenditures for HIV-infected patients.

Distribution of health care expenditures for HIV-infected patients.

http://www.wikidata.org/entity/Q42699465

about

Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice Costs and effectiveness of neonatal male circumcision Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies Should we treat acute HIV infection?Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing The prevalence of transmitted resistance to first-generation non-nucleoside reverse transcriptase inhibitors and its potential economic impact in HIV-infected patients Cost of treatment in a US commercially insured, HIV-1-infected population Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States.Antiretroviral drug costs and prescription patterns in British Columbia, Canada: 1996-2011.Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs.Recent key advances in human immunodeficiency virus medicine and implications for China A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada Short-term discontinuation of HAART regimens more common in vulnerable patient populations.RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma.Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.Enrollment, retention, and visit attendance in the University of North Carolina Center for AIDS Research HIV clinical cohort, 2001-2007.Opportunities to diagnose, treat, and prevent HIV in the criminal justice system.Hospitalization risk following initiation of highly active antiretroviral therapy Underutilization of the AIDS Drug Assistance Program: associated factors and policy implications.Health care system and policy factors influencing engagement in HIV medical care: piecing together the fragments of a fractured health care delivery system.Temporal trends in presentation for outpatient HIV medical care 2000-2010: implications for short-term mortality.California's "Bridge to Reform": identifying challenges and defining strategies for providers and policymakers implementing the Affordable Care Act in low-income HIV/AIDS care and treatment settings.The Direct Medical Costs of Late Presentation (<350/mm) of HIV Infection over a 15-Year Period.Late diagnosis of HIV infection: the role of age and sex.Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study Essential components of effective HIV care: a policy paper of the HIV Medicine Association of the Infectious Diseases Society of America and the Ryan White Medical Providers Coalition.Limited spending: an analysis of correctional expenditures on antiretrovirals for HIV-infected prisoners.The Affordable Care Act and low-income people living with HIV: looking forward in 2014 and beyond.Evidence of High Out of Pocket Spending for HIV Care Leading to Catastrophic Expenditure for Affected Patients in Lao People's Democratic Republic mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5.Determining the Cost-Savings Threshold for HIV Adherence Intervention Studies for Persons with Serious Mental Illness and HIV Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD.Cost-effectiveness of HIV screening in patients older than 55 years of age.Costs of health resource utilization among HIV-positive individuals in British Columbia, Canada: results from a population-level study.Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.The cost of antiretroviral therapy in Haiti.Contemporary costs of HIV healthcare in the HAART era HIV/AIDS: AIDS Drug Assistance Programs in the era of routine HIV testing.Uncompensated medical provider costs associated with prior authorization for prescription medications in an HIV clinic.

P2860

Q21090483-EA64088B-4F47-44DF-9B39-59F020308847 Q24630822-18E5ED43-5CCA-490E-82EF-36F9488C8E5B Q24656950-E7C7386E-1F94-4AF7-8701-CF0C86B3906A Q26826523-383BB693-B23E-44C8-A288-8758E0955D86 Q28469229-148166E5-8EB6-4B3A-90CC-BB5BDC25FFAF Q28535577-E3266799-37CC-40A6-9113-494E81D3B543 Q28539139-695AFA76-4B14-4C7F-BF09-E033A8591B66 Q33696533-525A3DC9-D310-4B99-AE1A-42C727CE0898 Q33713411-667A5C21-FDDE-4D54-A939-A5CC268D2F03 Q33795242-D961F13D-F3D4-4B8B-A3B0-EF9BB5EACA7B Q33933502-78C4FD0C-C8D9-4F91-9C84-D2D3952A6848 Q34009387-8355AA93-029B-495C-9062-21C606989461 Q34085103-745AEAEA-BD6F-4F4D-89A0-F2E8AED335E7 Q34121209-B04EAEEA-5492-48C6-8484-2D7A50BFBC69 Q34124290-29FC92F0-B5C2-42D2-9098-2600A798310C Q34213876-0C8E4EF3-3D96-4C9D-84CB-78B22695D0D1 Q34472876-46D0769E-5364-409D-A812-29BE68F6110C Q34802635-76C3E638-4E4D-452E-802F-C74C72BA6AB9 Q34990815-1C7ADBD4-F874-42CD-9ECF-C0CABD7898E6 Q35019905-55DFEB40-FDCC-4E8A-B655-366A806D08A1 Q35111895-5FBF9F52-9F88-4A0D-AB5C-8E2D5B07F586 Q35112164-F2D2070C-2E3A-470A-A146-9FF2CB1D1341 Q35195602-5484F3CE-E9E6-43EC-AD5B-866E64607EFD Q35248093-91178FAE-E123-4968-A7DE-4EA97DFF3319 Q35386113-E7E15510-90C7-4493-946B-4D724F816990 Q35488888-32EE29DC-1ECB-4E7F-B607-1EF30E8C79EF Q35645961-4252B695-3BF6-4DE1-9759-0CF440F2E115 Q35755774-BB65B095-51D1-4A7F-9D5D-494DB36DF734 Q35761213-702ECCDB-7835-4A55-8967-CBBA14B05B9E Q35770689-1E8F078C-8562-4BAF-98B7-13873D8A761D Q35773067-5EDBF4EA-E3EA-4952-A981-FB95CF088AE0 Q35790371-C1D84750-28FF-47C1-B652-C53A6346A981 Q36191220-7C83488C-0945-4BB5-AA5F-8BCA4329177C Q36368335-DE65EF21-F7C0-48C6-AC7D-8745281DAAC8 Q36379615-5E29E815-F9D9-436A-A126-F572CD7B3B52 Q36505229-9F50F5F6-2E3C-4723-A715-02B99FD19601 Q36512486-A4514D46-1F6A-47BE-80ED-1FCE80704E16 Q36550975-42FC8AEE-4C7F-4A2C-A786-87B7864C6864 Q36953504-8229F88E-4F5F-456E-BFE3-B0D19EFAE753 Q36967041-58A2C855-51D3-4CC8-8FD3-6955E57BD761

P2860

Distribution of health care expenditures for HIV-infected patients.

http://www.wikidata.org/entity/Q42699465

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Distribution of health care expenditures for HIV-infected patients.

@en

Distribution of health care expenditures for HIV-infected patients.

@nl

type

label

Distribution of health care expenditures for HIV-infected patients.

@en

Distribution of health care expenditures for HIV-infected patients.

@nl

prefLabel

Distribution of health care expenditures for HIV-infected patients.

@en

Distribution of health care expenditures for HIV-infected patients.

@nl

P1433

Q42699465-12A4878C-2D26-44DD-A93B-B15E08CC9D68

P1476

Q42699465-D6C05240-260A-46E5-9975-FFB6D81DDA7B

P2093

Q42699465-0093A0AB-B3F0-4420-9D50-F1E57E1B856C

Q42699465-11D37E31-351E-467D-91AE-1B49F49FF0EF

Q42699465-21DD709F-43CD-4DC1-822A-676BD608E1C6

Q42699465-2FFDAB6D-9A34-4A4C-8C26-7B49E844BA47

Q42699465-36946367-CB7E-449A-8DA1-79AC90BF212E

Q42699465-AB6745A6-8628-42AF-AD2C-D6396CC13004

Q42699465-B28CD8E0-95A6-418D-8CAC-8F1FAEB20189

Q42699465-B3443E40-EA9B-42BE-88ED-7276A247AE66

Q42699465-E04A0CA4-C7B2-4B55-B337-542DCC98DDC6

P2860

Q42699465-085FF97D-99DD-45CE-B53F-53A2E1D1F0D8

Q42699465-11C49E1B-8D7C-4B57-B264-D6D6DED6689B

Q42699465-34B13BD2-1155-4039-B2FF-D43E5AAFC970

Q42699465-54CD94BD-0692-4C3E-ADE2-D1E99E0731C8

Q42699465-6E774EB9-FAB9-4B2A-A1FE-6AF7452B01F7

Q42699465-9BABF44A-2BED-4E24-8DD9-D52F42460484

Q42699465-9C17A0C3-3DA6-48FA-ABFA-F83818D4169B

Q42699465-BCE65D8A-7783-4364-9542-9EBB5A8590FF

Q42699465-BDA68A8D-5ABB-4A21-B86C-C2EE5DA6743F

Q42699465-CA7ED804-917B-48D6-ADAA-0BC22A30E2EC

P304

Q42699465-DCFB1895-7804-48D2-851F-FCA0B38CEC80

P31

Q42699465-B5F59AF0-4050-4EBE-BA78-972F6AF27E07

P356

Q42699465-201EC290-7114-4FF9-8007-C139797DCA0F

P407

Q42699465-4A136DCC-D7F8-4CFB-965C-0DE68A87535F

P433

Q42699465-8F088589-9D13-4794-8830-4D8C47633C71

P478

Q42699465-8BC8C401-7DED-45BC-90F3-E371E19F25A0

P50

Q42699465-562F9A1B-F8F7-460F-8131-C2E3FD651AD3

Q42699465-A8C11F03-6B30-48BE-B31D-4C396DE0E0B4

Q42699465-EEA335A6-B18B-4BBC-9402-058FA422D0A0

P577

Q42699465-8628624C-AE2E-4DA4-B8CC-1960B8698965

P5875

Q42699465-ECBB89E7-F86C-4364-A988-A8D915344490

P698

Q42699465-70ED3C00-131B-46B6-8427-7B1434FBD9BA

P356

P1433

Clinical Infectious Diseases

P1476

Distribution of health care expenditures for HIV-infected patients.

@en

P2093

Beth K Stone

http://www.w3.org/2001/XMLSchema#string

Gretchen A Cloud

http://www.w3.org/2001/XMLSchema#string

James L Raper

http://www.w3.org/2001/XMLSchema#string

Jerome Carter

http://www.w3.org/2001/XMLSchema#string

Maria Pisu

http://www.w3.org/2001/XMLSchema#string

Michael J Mugavero

http://www.w3.org/2001/XMLSchema#string

Michael S Saag

http://www.w3.org/2001/XMLSchema#string

Neil A Accortt

http://www.w3.org/2001/XMLSchema#string

Stephanie Call

http://www.w3.org/2001/XMLSchema#string

P2860

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Estimating the national cost of treating people with HIV disease: patient, payer, and provider data.

Natural history of HIV infection in the era of combination antiretroviral therapy.

Cost effectiveness of combination HIV therapy: 3 years later.

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

Hospital and outpatient health services utilization among HIV-infected patients in care in 1999.

Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland.

Decreased medical expenditures for care of HIV-seropositive patients. The impact of highly active antiretroviral therapy at a US Veterans Affairs Medical Center.

Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults.

Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy.

P304

1003-1010

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/500453

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

Jeroan J. Allison

Andrew O Westfall

P577

2006-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7265622

http://www.w3.org/2001/XMLSchema#string

P698

16511767

http://www.w3.org/2001/XMLSchema#string